Seegene Partners with Microsoft to Realise ‘A World Free from All Diseases’

Seegne’s SG OneSystem aims to allow scientists to develop diagnostic tests covering diseases in all organisms utilising SGDDS through global collaboration.

Seegene Inc., a leading South Korean company providing a total solution for PCR molecular diagnostics, has selected Microsoft as the technology partner for its SG OneSystem business in London, UK, to realise 'a world free from all diseases.'

SG OneSystem is a global strategy by Seegene Inc., to realise ‘a world free from all diseases.’ Seegene’s OneSystem aims to allow scientists and experts to locally develop syndromic quantitative PCR diagnostic tests covering diseases in all organisms and fields through global collaboration.

As per the deal, Seegene's Digitalised Development System (SGDDS) will incorporate Microsoft Azure services, including Azure OpenAI Service. This integration will assist Seegene in managing data interaction and analysis for researchers dealing with the substantial data generated by SGDDS.

With this move, Seegene aims to form a global consortium with more companies, enhancing global capabilities to effectively address future pandemics and work collectively towards a disease-free world.

Sharing thoughts, Dr Jong-Yoon Chun, CEO & founder, Seegene "The strategic collaboration with Microsoft will allow us to have a more structured SG OneSystem business model. Through our joint efforts, we expect synergetic effects to pave the way for a world free from all diseases."

The collaboration aims to open a new chapter in the field of molecular diagnostics by digitally enhancing Seegene’s automated diagnostic reagent development system with the integration of Microsoft Azure AI solutions.

What the Partnership Deal Entails

As per the deal, Seegene with the help of Microsoft will propel the growth of its SG OneSystem business, a strategy by Seegene to share its unique syndromic quantitative PCR technologies with leading companies across the world to drive cross-industry innovation in molecular diagnostics.

The core feature of Seegene's syndromic PCR technologies is the ability to simultaneously test 14 pathogens that cause similar symptoms in a single tube and provide quantitative information on the infectivity profile to correlate with the severity of illness.

Moreover, Seegene will also implement Azure Trusted Research Environment (TRE) to ensure both privacy and regulatory adherence.

Additionally, Seegene will leverage Microsoft Fabric, a single AI-powered analytics platform, that will unify Seegene’s data and reshape how everyone accesses, manages, and acts on that data with capabilities that span data integration, data engineering, data science, data monitoring, real-time analytics, and business intelligence.

Realisation of a Disease-free World

To realise 'a world free from all diseases’, Seegene will work with Microsoft's global healthcare team to help further SG OneSystem's growth by advocating the collective vision, bridging potential partners, and jointly participating in SG OneSystem's annual symposium.

Reportedly, key events such as a declaration ceremony for scientific communities and other partners participating in the SG OneSystem business will be held within the first half of this year to commemorate the shared vision.

Emphasising the vision for a disease-free world, Elena Bonfiglioli, general manager, global health and life sciences, Microsoft, said, "We support Seegene's vision of realising 'a world free from all diseases.’ In addition to working with Seegene on its digital transformation, we will collaborate to discover global partners and to further enhance the healthcare ecosystem."

Seegene aims to improve the healthcare ecosystem with Microsoft by delivering accurate early disease diagnoses that provide the foundation for effective treatment and prevention.

Microsoft’s Recent Healthcare Initiatives

Recently, Microsoft unveiled healthcare-focussed functionalities for its Fabric data and analytics platform. Initially announced in May, this platform acts as a central hub for integrating data from various sources such as electronic health records, medical images, lab systems, medical devices, and claims systems.

In September, Microsoft and Mercy joined forces in a multi-year collaboration to explore the integration of generative AI, cloud technology, and various tools to alleviate the workload on healthcare employees.

Mercy planned to implement immediate use cases using Microsoft Azure OpenAI Service. This includes utilising generative AI-assisted patient messaging for addressing questions regarding lab results or other care topics in a conversational format.